A mediastinal mass is an abnormal growth in the mediastinum, the central compartment of your chest between the lungs. This area houses your heart, major blood vessels, windpipe, esophagus, and thymus gland. Masses here are rare, affecting roughly 0.01% of the adult population, but they range widely from harmless cysts to aggressive cancers. Where exactly the mass sits within the mediastinum is one of the strongest clues to what it might be.
Where in the Chest It Forms
The mediastinum is divided into three compartments, each containing different structures. The anterior compartment sits behind your breastbone and in front of the heart. It contains the thymus, a small immune organ that’s most active during childhood. The middle compartment holds the heart, the roots of the major blood vessels, the windpipe, and the main airways branching into each lung. The posterior compartment runs along the spine and contains the esophagus, the descending portion of the aorta, and a network of nerves.
Because each compartment holds different tissue, the type of mass that develops depends heavily on location. This is why imaging reports almost always specify which compartment a mass occupies. That single detail immediately narrows down the list of possibilities.
Types Found in the Front Compartment
Anterior mediastinal masses are the most commonly discussed, and doctors often remember them by the “4 Ts”: thymoma, teratoma, thyroid tissue, and “terrible” lymphoma.
Thymoma is a tumor of the thymus gland. On imaging it typically appears as a lobulated mass with smooth borders. Between 30% and 50% of people with thymomas also develop an autoimmune condition, most often myasthenia gravis, a disease that causes progressive muscle weakness. Ironically, this can be a fortunate pairing: patients whose thymoma triggers myasthenia gravis tend to be diagnosed at an earlier stage and are more likely to have their tumor completely removed.
Teratoma is a type of germ cell tumor, meaning it arises from the same kind of cells that produce eggs or sperm. Mature teratomas are usually benign and can contain a bizarre mix of tissue types, including fat, bone, and even teeth. On a CT scan, this patchwork of fat, soft tissue, and calcium is a near-giveaway. Immature teratomas contain less-developed tissue and behave more aggressively.
Thyroid tissue can extend below the neck into the chest. These substernal goiters have at least half their volume sitting below the collarbone. Radioactive iodine scans can confirm whether the mass contains functioning thyroid tissue, which helps distinguish it from other growths.
Lymphoma in the mediastinum tends to grow quickly. Rapidly worsening symptoms are a hallmark, along with what doctors call “B symptoms”: unexplained fevers, drenching night sweats, and unintentional weight loss. PET-CT scans are particularly useful here because they detect metabolically active cancer cells and are more accurate than standard CT for determining how far the disease has spread.
Types Found in the Middle and Back
Middle mediastinal masses are most often congenital cysts, meaning they formed during fetal development. Bronchogenic cysts, the most common type, tend to sit near the point where the windpipe splits into the two main airways. These fluid-filled sacs are typically benign but can cause problems if they press on the airway or become infected.
Posterior mediastinal masses are dominated by neurogenic tumors, which account for about 20% of all mediastinal tumors in adults and 35% in children. These grow from nerve tissue along the spine. Schwannomas are the single most common type, making up about half of all neurogenic mediastinal tumors, and they most often appear in people between 20 and 30 years old. Most are benign. In young children, neuroblastomas are a concern. These are highly aggressive cancers with a median age at diagnosis of just 22 months.
Together, thymomas, neurogenic tumors, and benign cysts account for roughly 60% of all mediastinal masses.
Symptoms a Mediastinal Mass Can Cause
Many mediastinal masses cause no symptoms at all and are discovered incidentally on a chest X-ray or CT scan done for another reason. When symptoms do appear, they’re usually caused by the mass pressing on nearby structures rather than by the tumor itself.
A mass pressing on the windpipe or airways can cause cough, wheezing, shortness of breath, or stridor (a high-pitched sound when breathing in). Pressure on the esophagus makes swallowing difficult. Compression of the nerve that controls the voice box leads to hoarseness, while pressure on the nerve that controls the diaphragm can cause hiccups or difficulty breathing when lying flat.
Superior Vena Cava Syndrome
One of the more serious complications occurs when a mass compresses or invades the superior vena cava, the large vein that drains blood from the head and arms back to the heart. This causes a recognizable pattern: swelling of the face and neck, distended veins in the neck and chest, and a puffy, reddish appearance of the face. Other signs include swelling in the arms, eye redness, headache, and in severe cases, confusion or altered consciousness. Symptoms typically develop over days to weeks. This situation requires prompt evaluation because it signals significant obstruction of blood flow.
How a Mediastinal Mass Is Diagnosed
The diagnostic process generally follows a stepwise approach. A chest X-ray is usually the first test, and it can localize the mass to a specific compartment, which immediately narrows the possibilities. CT with contrast dye is the next step and provides far more detail. CT can distinguish fat, fluid, and calcium within the mass, which is often enough to identify mature teratomas or cysts without a biopsy.
PET-CT scans add limited value over standard CT for most mediastinal masses, with one important exception: lymphoma. For suspected lymphoma, PET-CT is essential for staging and follow-up because it detects active disease more reliably than CT alone.
Blood work plays a key role when germ cell tumors are suspected. Three markers are routinely checked: AFP (alpha-fetoprotein), beta-hCG (a hormone also elevated in pregnancy), and LDH (an enzyme released by damaged cells). A beta-hCG level above 1,000 U/L, with or without elevated AFP, strongly supports a germ cell tumor diagnosis in the right clinical context. Elevated AFP specifically rules out a pure seminoma, which matters because the treatment approach differs. These blood tests are recommended for any anterior mediastinal mass, even when no symptoms are present.
When a tissue sample is needed, the preferred method has shifted in recent years. Endobronchial ultrasound with needle biopsy (a camera-guided needle passed through the airway wall) has largely replaced the older surgical approach of mediastinoscopy as the first-choice procedure. Across nearly 3,000 patients studied over a decade, the needle-based technique achieved a sensitivity of 88% to 93% and a specificity of 100%, with accuracy comparable to or better than mediastinoscopy. It’s also less invasive and more cost-effective. Surgical biopsy is still performed selectively when the needle approach is inconclusive or when there’s a high likelihood the mass is cancerous.
Treatment Approaches
Treatment depends entirely on the type of mass. Benign cysts may only need monitoring if they aren’t causing symptoms. Functioning thyroid tissue extending into the chest is managed through thyroid-directed treatments. Lymphomas are treated with chemotherapy, radiation, or both.
For solid tumors like thymomas and many neurogenic tumors, surgery is the primary treatment. The degree of tumor invasion, meaning how deeply it has grown into surrounding structures, is generally a more important predictor of outcome than the tumor’s microscopic appearance. Complete surgical removal is one of the strongest factors associated with a good prognosis.
Traditional surgery involves splitting the breastbone (sternotomy), which provides excellent access but is highly invasive. Minimally invasive approaches using video-assisted thoracoscopic surgery (VATS) have become the preferred option worldwide. Compared to open surgery, VATS results in less blood loss, shorter hospital stays, shorter time with a chest drainage tube, and fewer complications, with equivalent cancer outcomes. A newer variation that uses a small incision below the breastbone (the subxiphoid approach) causes even less pain and blood loss than the standard side-of-the-chest VATS technique.
Outlook and Survival
Across all types of mediastinal masses, the overall five-year survival rate is about 88%. For confirmed malignant masses specifically, the five-year survival rate drops to roughly 71%, with an average survival of about 59 months. Early-stage thymomas that are completely removed carry a particularly favorable prognosis.
The wide range in outcomes reflects the diversity of what a “mediastinal mass” can actually be. A benign cyst discovered by accident carries essentially no risk to your life, while an aggressive lymphoma or immature germ cell tumor requires intensive treatment. This is why pinpointing the exact type and stage through imaging, blood work, and often a biopsy is the critical first step in determining what comes next.